1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide
TL;DR: 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide (CAS 300-22-1) is a chemical compound with molecular formula C6H9N3O2 and molecular weight 155.06947 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
1-methyl-6-oxo-4,5-dihydropyridazine-3-carboxamide
Also Known As: Medazomida, medazonamide, Medazomidum, Medazomide [INN], Medazonamid
Application Areas
Top 5 of 1 IPC patent classification(s) from the SureChEMBL global patent database.
Technical Specifications
| Molecular Formula | C6H9N3O2 |
| Molecular Weight | 155.06947 g/mol |
| XLogP | -1.6 |
| Topological Polar Surface Area (TPSA) | 75.8 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 3 |
| Rotatable Bonds | 1 |
| Exact Mass | 155.06947 Da |
| Heavy Atoms | 11 |
| Complexity | 234.0 |
| SMILES | CN1C(=O)CCC(=N1)C(=O)N |
| InChIKey | LXFKHPXXAPOYCC-UHFFFAOYSA-N |
Product Description
Applications: 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide is used in pharmaceutical synthesis routes and API production. It commonly serves as a versatile building block for organic synthesis. Available from CoreyChem as both catalog item and custom-synthesis project (mg to ton scale), with full analytical documentation (COA, MSDS, HPLC, NMR, MS).
1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide is a pharmaceutical intermediate identified by CAS number 300-22-1 and the molecular formula C6H9N3O2 and a molecular weight of 155.07 g/mol. Synonyms include Medazomida and medazonamide.
Custom synthesis and full analytical documentation (COA/MSDS) are available from CoreyChem. Request a quotation with your required quantity and purity for current lead time and pricing.
Chemical Property Profile of 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide
Property Insights of 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide
The XLogP value of -1.6 indicates that 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide is hydrophilic (water-soluble), making it suitable for aqueous formulations and biological assay applications. The TPSA of 75.8 Ų falls within the moderate polarity range, balancing permeability and solubility for 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide. Following Lipinski's Rule of Five, 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide has 1 hydrogen bond donor(s) and 3 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
What is the CAS number of 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide?
The CAS number of 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide is 300-22-1.
What is the molecular formula of 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide?
The molecular formula of 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide is C6H9N3O2.
What is the molecular weight of 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide?
The molecular weight of 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide is 155.06947 g/mol.
What are the applications of 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide?
1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide is used in pharmaceutical synthesis routes and API production. It commonly serves as a versatile building block for organic synthesis. Available from CoreyChem as both catalog item and custom-synthesis project (mg to ton scale), with full...
Where can I buy 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide?
You can request a quote for 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Does CoreyChem offer custom synthesis for 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide?
Yes, CoreyChem provides custom synthesis services for 1,4,5,6-Tetrahydro-1-methyl-6-oxo-3-pyridazinecarboxamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.